Bridgeway Capital Management, LLC Zynerba Pharmaceuticals, Inc. Call Options Transaction History
Bridgeway Capital Management, LLC
- $4.44 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ZYNE
# of Institutions
4Shares Held
774KCall Options Held
0Put Options Held
0About Zynerba Pharmaceuticals, Inc.
- Ticker ZYNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,753,100
- Description
- Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...